Thuja Capital is structured to invest in early stage healthcare (life science) innovations with a focus on biotechnology, diagnostics and medical devices. Thuja Capital is the manager of Thuja Capital Healthcare (Seed) Fund, two venture capital funds dedicated to life science investments. The prime focus of these two funds are start-up and early-stage life science companies, whereby the Seed Fund is restricted to the Netherlands.
Furthermore, Thuja Capital is the exclusive manager of Alpinvest Partner’s portfolio of early-stage life science companies.
Thuja Capital’s team believes in building and sustaining a close relationship with the management of companies we invest in. By taking an active role, Thuja Capital aims to help these companies to strengthen and grow their businesses. In addition to this, our broad network of advisors and relationships with other private equity firms allows us to play a significant role in the realization of strategic objectives and additional fundraising.